144 related articles for article (PubMed ID: 28508247)
41. Effect of immunosuppressive drugs on DNA repair in human peripheral blood mononuclear cells.
Herman-Edelstein M; Rozen-Zvi B; Zingerman B; Lichtenberg S; Malachi T; Gafter U; Ori Y
Biomed Pharmacother; 2012 Mar; 66(2):111-5. PubMed ID: 22244961
[TBL] [Abstract][Full Text] [Related]
42. Effects of resveratrol on Th17 cell-related immune responses under tacrolimus-based immunosuppression.
Doh KC; Kim BM; Kim KW; Chung BH; Yang CW
BMC Complement Altern Med; 2019 Mar; 19(1):54. PubMed ID: 30832648
[TBL] [Abstract][Full Text] [Related]
43. Safety of mTOR inhibitors in adult solid organ transplantation.
Ventura-Aguiar P; Campistol JM; Diekmann F
Expert Opin Drug Saf; 2016; 15(3):303-19. PubMed ID: 26667069
[TBL] [Abstract][Full Text] [Related]
44. Calcineurin antagonists inhibit interferon-gamma production by downregulation of interleukin-18 in human mixed lymphocyte reactions.
Kuinose M; Iwagaki H; Morimoto Y; Kohka H; Kobashi K; Sadamori H; Inagaki M; Urushihara N; Yagi T; Tanaka N
Acta Med Okayama; 2000 Oct; 54(5):201-9. PubMed ID: 11061569
[TBL] [Abstract][Full Text] [Related]
45. Conversion of stable ABO-incompatible kidney transplant recipients from mycophenolate mofetil with standard exposure calcineurin inhibitors (CNIs) to everolimus with very low exposure CNIs-a short-term pilot study.
Uchida J; Machida Y; Iwai T; Kuwabara N; Kabei K; Naganuma T; Kumada N; Kawashima H; Nakatani T
Clin Transplant; 2014 Jan; 28(1):80-7. PubMed ID: 24329776
[TBL] [Abstract][Full Text] [Related]
46. Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial.
Budde K; Becker T; Arns W; Sommerer C; Reinke P; Eisenberger U; Kramer S; Fischer W; Gschaidmeier H; Pietruck F;
Lancet; 2011 Mar; 377(9768):837-47. PubMed ID: 21334736
[TBL] [Abstract][Full Text] [Related]
47. Pharmacodynamic Drug-Drug Interaction on Human Peripheral Blood Mononuclear Cells Between Everolimus and Tacrolimus at the Therapeutic Concentration Range in Renal Transplantation.
Okihara M; Takeuchi H; Akiyama S; Yoshinaga R; Osato S; Akashi I; Kihara Y; Konno O; Iwamoto H; Oda T; Tanaka S; Unezaki S; Hirano T
Ann Transplant; 2021 Feb; 26():e928817. PubMed ID: 33633104
[TBL] [Abstract][Full Text] [Related]
48. Calcineurin inhibitors dampen humoral immunity by acting directly on naive B cells.
De Bruyne R; Bogaert D; De Ruyck N; Lambrecht BN; Van Winckel M; Gevaert P; Dullaers M
Clin Exp Immunol; 2015 Jun; 180(3):542-50. PubMed ID: 25682989
[TBL] [Abstract][Full Text] [Related]
49. Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin.
Hoogduijn MJ; Crop MJ; Korevaar SS; Peeters AM; Eijken M; Maat LP; Balk AH; Weimar W; Baan CC
Transplantation; 2008 Nov; 86(9):1283-91. PubMed ID: 19005411
[TBL] [Abstract][Full Text] [Related]
50. Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation.
Hostettler KE; Halter JP; Gerull S; Lardinois D; Savic S; Roth M; Tamm M
Eur Respir J; 2014 Jan; 43(1):221-32. PubMed ID: 23645405
[TBL] [Abstract][Full Text] [Related]
51. Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients.
Fukudo M; Yano I; Masuda S; Fukatsu S; Katsura T; Ogura Y; Oike F; Takada Y; Tanaka K; Inui K
Clin Pharmacol Ther; 2005 Aug; 78(2):168-81. PubMed ID: 16084851
[TBL] [Abstract][Full Text] [Related]
52. [Therapeutic monitoring of immunosuppressive drugs: interest of calcineurin activity assessment in liver transplantation].
Blanchet B
Ann Pharm Fr; 2008 Mar; 66(2):96-101. PubMed ID: 18570908
[TBL] [Abstract][Full Text] [Related]
53. The safety of calcineurin inhibitors for kidney-transplant patients.
Malvezzi P; Rostaing L
Expert Opin Drug Saf; 2015 Oct; 14(10):1531-46. PubMed ID: 26329325
[TBL] [Abstract][Full Text] [Related]
54. Effect of different immunosuppressive drugs on immune cells from young and old healthy persons.
Welzl K; Kern G; Mayer G; Weinberger B; Säemann MD; Sturm G; Grubeck-Loebenstein B; Koppelstaetter C
Gerontology; 2014; 60(3):229-38. PubMed ID: 24434865
[TBL] [Abstract][Full Text] [Related]
55. Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil.
Sun Q; Liu ZH; Cheng Z; Chen J; Ji S; Zeng C; Li LS
Kidney Int; 2007 Jan; 71(1):24-30. PubMed ID: 16969384
[TBL] [Abstract][Full Text] [Related]
56. Effects of everolimus on cellular and humoral immune processes leading to chronic allograft nephropathy in a rat model with sensitized recipients.
Koch M; Mengel M; Poehnert D; Nashan B
Transplantation; 2007 Feb; 83(4):498-505. PubMed ID: 17318083
[TBL] [Abstract][Full Text] [Related]
57. Effects of sotrastaurin, mycophenolic acid and everolimus on human B-lymphocyte function and activation.
Matz M; Lehnert M; Lorkowski C; Fabritius K; Unterwalder N; Doueiri S; Weber UA; Mashreghi MF; Neumayer HH; Budde K
Transpl Int; 2012 Oct; 25(10):1106-16. PubMed ID: 22816666
[TBL] [Abstract][Full Text] [Related]
58. The pharmacokinetics of everolimus in de novo kidney transplant patients receiving tacrolimus: an analysis from the randomized ASSET study.
Rostaing L; Christiaans MH; Kovarik JM; Pascual J
Ann Transplant; 2014 Jul; 19():337-45. PubMed ID: 25017487
[TBL] [Abstract][Full Text] [Related]
59. Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial.
Favi E; Spagnoletti G; Salerno MP; Pedroso JA; Romagnoli J; Citterio F
Clin Transplant; 2013; 27(4):E359-67. PubMed ID: 23710603
[TBL] [Abstract][Full Text] [Related]
60. Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial.
Gullestad L; Iversen M; Mortensen SA; Eiskjaer H; Riise GC; Mared L; Bjørtuft O; Ekmehag B; Jansson K; Simonsen S; Gude E; Rundqvist B; Fagertun HE; Solbu D; Bergh CH
Transplantation; 2010 Apr; 89(7):864-72. PubMed ID: 20061999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
